“…[192] Following IC application in vivo to osteoporosis, osteoarthritis and implant osteointegration conditions, constituents of this pathway (Wnt1, Wnt3a, Wnt10b, LRP5/6, β-catenin) were observed to be more expressed or active, both in human and non-human studies; contrarily, endogenous inhibitors of this pathway (DKK-1, Axin2, SOST, PPAR-γ) had their gene expression reduced. [87,88,98,120,[122][123][124]127,183,193] Another widely known osteogenic signaling pathway that cross-talks with the Wnt pathway is the TGF-β/BMP (2/5/7) signaling pathway, which is also found to increase following IC stimulation. [111,124,163,193] Wnt and BMP pathways can intricately regulate each other through synergistic signaling and feedback systems at all levels (ligand production, interaction of intermediates and effectors).…”